Comparison of positron emission tomography with 68Ga-DOTA-TATE and 18F FDG in neuroendocrine tumours

被引：0
|
作者：
Yilmaz, S. [1 ]
Demirci, E. [1 ]
Ocak, M. [2 ]
Gunes, B. [1 ]
Kabasakal, L. [1 ]
Halac, M. [1 ]
Araman, A. [2 ]
Decristoforo, C. [3 ]
Uslu, I. [1 ]
机构：
[1] Istanbul Univ, Dept Nucl Med, Cerrahpasa Fac Med, Istanbul, Turkey
[2] Istanbul Univ, Fac Pharm, Dept Pharmaceut Technol, Istanbul, Turkey
[3] Med Univ Innsbruck, Clin Dept Nucl Med, A-6020 Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2011年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S382 / S382
页数：1
相关论文
共 50 条
  • [31] Lebanese experience with 68Ga-DOTA-TATE PET/CT in the diagnosis and management of Neuroendocrine tumors.
    Haidar, M.
    Chehade, F.
    Asmar, R.
    Jriege, M.
    Khoury, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S376 - S376
  • [32] Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy
    Aurora Sainz-Esteban
    Vikas Prasad
    Christiane Schuchardt
    Carolin Zachert
    José Manuel Carril
    Richard P. Baum
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 501 - 511
  • [33] Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy
    Sainz-Esteban, Aurora
    Prasad, Vikas
    Schuchardt, Christiane
    Zachert, Carolin
    Manuel Carril, Jose
    Baum, Richard P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (03) : 501 - 511
  • [34] Is [68Ga]DOTA-TATE- or [18F]DOPA-PET/CT preferable for the diagnosis of neuroendocrine tumors (NET)?
    Haug, A. R.
    Auernhammer, C.
    Bartenstein, P.
    Tiling, R.
    Waengler, B.
    Poepperl, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S267 - S267
  • [35] Early monitoring of the atherosclerosis plaque formation by 68Ga-DOTA-TATE, 68Ga-LLP2A and 18F-FDG: a preliminary study by head-to-head comparation
    Song, Wenyu
    Song, Yangmeihui
    Qin, Chunxia
    Gai, Yongkang
    Zhang, Xiao
    Lan, Xiaoli
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [36] An Intrapatient Comparison of 99mTc-HYNIC-TOC with 68Ga-DOTA-TATE for Imaging Abilities of Gastroenteropancreatic Neuroendocrine Neoplasms
    Yu, J.
    Li, J.
    Yang, Z.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 117 - 117
  • [37] Imaging of multiple brown tumors both in FDG (18F) and 68Ga DOTA-TATE PET/CT studies
    Asa, S.
    Yilmaz, S.
    Kaya, R.
    Sager, S.
    Halac, M.
    Kabasakal, L.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (06): : 404 - 405
  • [38] Use of 68Ga-DOTA-TATE PET/CT for predicting the dose of 177Lu-DOTA-TATE therapy in patients with neuroendocrine tumors (NETs)
    Scheler, Simone
    Fischer, Richard
    Fani, Melpomeni
    Maecke, Helmut
    Weber, Wolfgang
    Wild, Damian
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [39] Comparison of [18F]fluorodeoxyglucose and [68Ga]Gallium DOTA-TATE in patients with active giant cell arteritis
    Clifford, Alison H.
    Abele, Jonathan
    Hung, Ryan
    Wuest, Frank
    Andersson, Jan
    Pike, Susan
    Yacyshyn, Elaine
    Lenza, Eric
    Jickling, Glen
    Raggi, Paolo
    Tervaert, Jan Willem Cohen
    EJNMMI REPORTS, 2025, 9 (01)
  • [40] Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography
    Koch, Walter
    Auernhammer, Christoph J.
    Geisler, Julia
    Spitzweg, Christine
    Cyran, Clemens C.
    Ilhan, Harun
    Bartenstein, Peter
    Haug, Alexander R.
    MOLECULAR IMAGING, 2014, 13
12345